XOMA Royalty (XOMA) Stock Forecast & Price Target

XOMA Forecast - Frequently Asked Questions

What is XOMA Royalty's forecast for 2026?

According to the research reports of 7 Wall Street equities research analysts, the average twelve-month stock price forecast for XOMA Royalty is $53.75, with a high forecast of $76.00 and a low forecast of $39.00.

Should I buy or sell XOMA Royalty stock right now?

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for XOMA Royalty in the last twelve months. There are currently 5 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" XOMA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in XOMA, but not buy additional shares or sell existing shares.

Does XOMA Royalty's stock price have much upside?

According to analysts, XOMA Royalty's stock has a predicted upside of 29.21% based on their 12-month stock forecasts.

Has XOMA Royalty been upgraded or downgraded by Wall Street analysts recently?

Over the previous 90 days, XOMA Royalty's stock had 3 upgrades and 3 downgrades by analysts.

What analysts cover XOMA Royalty?

XOMA Royalty has been rated by research analysts at HC Wainwright, Leerink Partners, Lucid Cap Mkts, TD Cowen, and Zacks Research in the past 90 days.

Do Wall Street analysts like XOMA Royalty more than its competitors?

Analysts like XOMA Royalty less than other "medical" companies. The consensus rating score for XOMA Royalty is 2.29 while the average consensus rating score for "medical" companies is 2.30. Learn more on how XOMA compares to other companies.